Argentina Ophthalmic Devices Market - Growth, Trends, and Forecasts 2017 - 2022

  • ID: 4387777
  • Report
  • Region: Argentina
  • 70 pages
  • Mordor Intelligence
1 of 3
Argentina’s market for ophthalmic devices is currently valued at USD XX billion for the year 2016 and is expected to reach USD XX billion by the end of 2021. The CAGR during this period of the forecast is projected to be XX%.

Latin America is filled with immense potential and could very well dominate the market in the future, overtaking Europe and Asia-Pacific. Brazil is currently spearheading the Latin American market with important contributions from Argentina, Chile, and Mexico.

This escalation is developing the need to analyze, review and forecast the growth of the ophthalmic devices market. Owing to the rapid evolution of the market in the use of medical technology, medical device companies that are able to launch new innovative equipment will be rewarded with huge benefits.

Argentina Ophthalmic Devices Market-Market Dynamics

The report details several factors driving and restraining the market. Some of these are discussed below.


Growth in cataract volume, availability of new drugs and devices, the demographic shift and increased impact of the prevalence of eye disease are the major factors driving the growth of this market.


Increasing healthcare costs and economic slowdown in developed markets are the major challenges faced by the ophthalmic device market.

The report studies in detail the different ophthalmic devices, which include lasers, surgery devices, ophthalmic diagnostic devices, rings, implants, and lens.

This Report Offers:

Market analysis for Argentina’s ophthalmic devices market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share for the next five years.
Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
The various applications of ophthalmic devices have been discussed in detail, in addition to a comprehensive overview of the market.
Note: Product cover images may vary from those shown
2 of 3
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Applications of In-Vitro Diagnostics
5.3 Technology Overview
5.4 New Developments
5.5 Industry Value-Chain Analysis
5.6 Product Life-Cycle Analysis
5.7 Product Benchmarking
5.8 Investment Analysis
5.8 Porter’s Five Forces
5.8.1 Bargaining Power of Suppliers
5.8.2 Bargaining Power of Consumers
5.8.3 Threat of New Entrants
5.8.4 Threat of Substitute Products and Services
5.8.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.1.1 Rapid Increase in the Chronic Diseases
6.1.2 Increasing Number of Private Hospitals and Independent Testing Laboratories
6.1.3 Government Initiatives
6.1.4 Technological Advances
6.1.5 Aging Population
6.2 Market Restraints
6.2.1 Lack of Expertise in Advanced Technologies
6.2.2 Price Concern
6.2.3 Lack of Proper Reimbursement Policies
6.2.4 Stringent Regulatory Framework
6.3 Key Challenges
6.4 Current Opportunities in the Market
7. Market Segmentation
7.1 By Technology
7.1.1 Clinical Chemistry
7.1.2 Immunoassays
7.1.3 Hematology
7.1.4 Coagulation and Hemostasis
7.1.5 Microbiology
7.1.6 Point Of Care Diagnostics
7.1.7 Molecular Diagnostics
7.2 By Product
7.2.1 Instruments
7.2.2 Reagents
7.2.3 Data Management Systems and Services
7.3 By Usability
7.3.1 Disposable IVD Devices
7.3.2 Reusable IVD Devices
7.4 By End-User
7.4.1 Hospitals
7.4.2 Laboratories
7.4.3 Academics
7.4.4 Point Of Care Testing
7.5 By Application
7.5.1 Infectious Diseases
7.5.2 Diabetes
7.5.3 Oncology
7.5.4 Cardiology
7.5.5 Autoimmune Diseases
7.5.6 Nephrology
7.5.7 HIV/AIDS
7.5.8 Drug testing
7.5.9 Others
8. Competitive Landscape
8.1 Merger and Acquisition Analysis
8.2 New Product Launches
8.3 Agreements, Collaborations & Partnerships
9. Company Profiles
9.1 Roche Diagnostics
9.2 Abbott Laboratories
9.3 Bio-Rad Laboratories, Inc.
9.4 Danaher Corporation
9.5 Johnson & Johnson
9.6 Siemens Healthcare
9.7 Becton, Dickinson, and Company
9.8 Thermo Fisher Scientific, Inc.
10. Analyst Outlook for Investment Opportunities
11. Future Outlook of the Market
Note: Product cover images may vary from those shown
3 of 3


4 of 3
Note: Product cover images may vary from those shown